Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for HGH Treatments

Posted by Matt Breese on Jan 11, 2018

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is human growth hormone (HGH) treatments. 

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Read More

Topics: Market Access, Data & Analytics

MMIT Reality Check on Growth Hormones (Jan 2018)

Posted by Matt Breese on Jan 8, 2018

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Data & Analytics, Branding & Marketing

Perspectives on Wearable Device Data

Posted by Matt Breese on Dec 27, 2017

In 2018, we will see a rising amount of health-related data generated from personal devices such as smartphones and wearables. One potential application for these tools is to monitor patients in clinical trials remotely.
 
Historically, some concerns with wearable device-derived data have been the lack of regulatory guidance and the difficulty of ensuring data quality.
 
Read More

Topics: Data & Analytics

Perspectives on Real-World Data

Posted by Matt Breese on Nov 7, 2017

The pharmaceutical industry has seen an explosion in the availability of real-world data in recent years. In the past, pharma companies mainly relied on data from clinical trials. Today, real-world data provides new insights and opportunities to assess a broader population.

This information is increasingly influencing healthcare decision-makers. However, data scientists must have the skills to sort through unstructured health data, analyze it, understand the big picture, and portray the data visually. 

Read More

Topics: Industry Trends, Data & Analytics

Perspectives on Translating Data into Powerful Stories

Posted by Matt Breese on Aug 1, 2017

Mark Twain popularized the saying, “There are three kinds of lies: lies, damned lies and statistics.” We often think that including numbers in a presentation will engage our audience – isn’t the data evidence enough to make our audience take note and pay attention?

No. Most sales and marketing teams armed with a wealth of data struggle to deliver meaning in a context that’s relevant.

Read More

Topics: Market Access, Data & Analytics

MMIT Reality Check on Growth Hormones (Jul 2017)

Posted by Matt Breese on Jul 18, 2017

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Data & Analytics, Branding & Marketing

Trends That Matter for Biomarker Research

Posted by Matt Breese on May 2, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is biomarker research and development. Biomarkers are used to monitor health status, detect conditions, and select the most effective treatment options. In the pharma industry, biomarkers are also used to determine the safety and effectiveness of drugs based on overall population data and individual patient information. 

As biomarker research expands and data access improves, clinicians will have greater ability to deliver personalized care, contributing to the value-based care shift. According to biochemistry research by Timothy J. Hagen and Northern Illinois University

Read More

Topics: Industry Trends, Data & Analytics

Market Access is Getting Harder

Posted by Matt Breese on Mar 24, 2017

Market access is getting harder.  We’ve seen this first hand with over 85 manufacturer clients and over 60 payer/PBM clients but anyone close to the industry feels the impact. Pharma pipelines expand with historical amounts of highly managed products in complex disease areas as brands launch into the market. 

Read More

Topics: Specialty, Market Access, Data & Analytics, Branding & Marketing

Trends That Matter for Pharma Data

Posted by Matt Breese on Mar 23, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is pharma data. Electronic Health Records (EHRs) help clinicians manage healthcare data.  In fact, 83% of physicians use EHRS, according to Medical Marketing and Media.

The Centers for Medicare and Medicaid Services describes the multitude of benefits EHRs provide:

"An Electronic Health Record (EHR) is an electronic version of a patients medical history, that is maintained by the provider over time, and may include all of the key administrative clinical data relevant to that persons care under a particular provider, including demographics, progress notes, problems, medications, vital signs, past medical history, immunizations, laboratory data and radiology reports." 

Read More

Topics: Industry Trends, Data & Analytics

MMIT Reality Check on Growth Hormones (Jan 2017)

Posted by Matt Breese on Jan 27, 2017

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Data & Analytics, Branding & Marketing